GlassScriptPhysician profile
Samuel Burns
NPI 1336532332
$9,764.96
in general payments reported to CMS, 2019-2025
25 companies · $2,664 in 2025
The $2,664 reported for 2025 was more than what 75% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,435 · 2020: $166 · 2021: $1,985 · 2022: $1,448 · 2023: $294 · 2024: $1,772 · 2025: $2,664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,657 · Travel and Lodging: $2,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,656.88 |
| Travel and Lodging | $2,073.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rattan and Associates | $3,548.45 | 2021-2025 | |
| Stryker Corporation | $2,068.99 | 2020-2025 | Mako, Gmrs, Insignia |
| Zimmer Biomet Holdings, INC. | $1,514.72 | 2019-2020 | |
| Arthrex, INC. | $882.98 | 2025 | |
| Vericel Corporation | $461.13 | 2021 | |
| Orthalign INC | $295.48 | 2021-2024 | Orthalign Plus |
| Si-Bone, INC. | $103.51 | 2022-2024 | |
| Embody, INC. | $102.46 | 2023 | |
| Axogen | $87.26 | 2025 | |
| Innovation Technologies INC | $85.59 | 2023 | Irrisept |
| Illuminoss Medical, INC. | $76.00 | 2025 | |
| Paragon 28, INC. | $74.41 | 2019 | |
| Osteocentric Technologies, INC. | $73.65 | 2024-2025 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Nalu Medical, INC. | $69.34 | 2025 | Nalu Neurostimulation System |
| Linvatec Corporation | $51.59 | 2023 | Biobrace 23mm |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $44.78 | 2022-2025 | Exparel |
| Next Science LLC | $34.08 | 2023 | Xperience, Surgx, Blastx |
| Vertex Pharmaceuticals Incorporated | $32.89 | 2025 | |
| Heron Therapeutics, INC. | $30.21 | 2021-2022 | |
| Biocomposites INC | $28.92 | 2024 | |
| Terumo Bct, INC. | $23.04 | 2022 | |
| Kci USA, INC. | $21.05 | 2022 | |
| Smith+Nephew, INC. | $20.34 | 2022 | |
| Orthopediatrics Corp. | $18.41 | 2025 | |
| Orthofix Medical, INC. | $15.68 | 2025 | Truelok |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Burns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.